Check out the latest Point and Counterpoint article: Should All Patients With Idiopathic Pulmonary Fibrosis, Even Those With More Than Moderate Impairment, Be Treated With Nintedanib or Pirfenidone?
Check out the recent Giants in Chest Medicine article: Giants in Chest Medicine: Neil R. MacIntyre, MD, FCCP
New Article: The A's Have It: Developing Apolipoprotein A-I Mimetic Peptides Into a Novel Treatment for Asthma
New Article: Cancer and OSA: Current Evidence From Human Studies
New! Occupational and Environmental Contributions to Chronic Cough in Adults: CHEST Expert Panel Report (Online First)
New! Evaluation of Pulmonary Nodules: Clinical Practice Consensus Guidelines for Asia (Online First)
New! Technical Aspects of Endobronchial Ultrasound Guided Transbronchial Needle Aspiration: CHEST Guideline and Export Panel Report (March 2016)
New! Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report (February 2016)
Become a CHEST member and receive a FREE subscription as a benefit of membership.
Individuals can purchase this article on ScienceDirect.
Individuals can purchase a subscription to the journal.
Individuals can purchase a subscription to the journal or buy individual articles.
Learn more about membership or Purchase a Full Subscription.
Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.